Cite
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
MLA
Yndigegn, Troels, et al. “Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.” The New England Journal of Medicine, vol. 390, no. 15, Apr. 2024, pp. 1372–81. EBSCOhost, https://doi.org/10.1056/NEJMoa2401479.
APA
Yndigegn, T., Lindahl, B., Mars, K., Alfredsson, J., Benatar, J., Brandin, L., Erlinge, D., Hallen, O., Held, C., Hjalmarsson, P., Johansson, P., Karlström, P., Kellerth, T., Marandi, T., Ravn-Fischer, A., Sundström, J., Östlund, O., Hofmann, R., & Jernberg, T. (2024). Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. The New England Journal of Medicine, 390(15), 1372–1381. https://doi.org/10.1056/NEJMoa2401479
Chicago
Yndigegn, Troels, Bertil Lindahl, Katarina Mars, Joakim Alfredsson, Jocelyne Benatar, Lisa Brandin, David Erlinge, et al. 2024. “Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.” The New England Journal of Medicine 390 (15): 1372–81. doi:10.1056/NEJMoa2401479.